Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
| Novartis Pharmaceuticals Corporation |
| Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc., Lupin Limited and Lupin Inc. |
| 1:2020cv00415 |
| March 24, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 18, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 ANSWER to #11 Answer to Complaint,, Counterclaim, by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Pro Hac Vice Attorney Jared L. Stringham for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Pro Hac Vice Attorney Carol M. Pitzel Cruz, William R. Zimmerman, and Andrea L. Cheek for Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Carol Pitzel Cruz, and Andrea L. Cheek filed by Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/28/20. (ntl)
|
| CORRECTING ENTRY: Defendant Lupin Limited, Lupin Inc. are two separate parties, not one. Due to clerical error.(myr) |
| Pro Hac Vice Attorneys Nicholas N. Kallas and Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Filing 15 NOTICE of Appearance by Alexandra M. Ewing on behalf of Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc., Lupin Pharmaceuticals, Inc. (Ewing, Alexandra) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Carol Pitzel Cruz, and Andrea L. Cheek - filed by Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc., Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Limited, Lupin Inc., Lupin Limited, Lupin Inc.; Corporate Parent Lupin, Ltd. for Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. filed by Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc., Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Filing 12 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,404,744 . (Cottrell, Frederick) |
| Filing 11 ANSWER to #1 Complaint, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc.. (Attachments: #1 Exhibit 1, #2 Patent/Trademark Report)(Cottrell, Frederick) |
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz and Jared L. Stringham filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 4/15/20. (ntl)
|
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certification of Counsel of Nicholas N. Kallas, #2 Certification of Counsel of Christina Schwarz, #3 Certification of Counsel of Jared L. Stringham)(Silver, Daniel) |
| Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: (Silver, Daniel) |
| Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited, Lupin Inc. waiver sent on 3/24/2020, answer due 5/26/2020. (Silver, Daniel) |
| Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 3/24/2020, answer due 5/26/2020. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 3/24/2020, answer due 5/26/2020. (Silver, Daniel) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659 ;8,796,331 ;8,877,938 ;9,388,134. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 12, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 7/7/2023. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2884292.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(myr) |
| No Summons Issued. (myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
